47962 Federal Register / Vol. 74, No. 180 / Friday, September 18, 2009 / Notices 

the basic classes of controlled 

substances listed. 

Dated: September 14, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–22505 Filed 9–17–09; 8:45 am] 

BILLING CODE 4410–09–M 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances 

Notice of Registration 

By Notice dated June 15, 2009, and 

published in the Federal Register on 

June 23, 2009 (74 FR 29718), Aptuit, 

10245 Hickman Mills Drive, Kansas 

City, Missouri 64137, made application 

by renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of Marihuana (7360), a basic 

class of controlled substance listed in 

schedule I. 

The company plans to import a 

finished pharmaceutical product 

containing cannabis extracts in dosage 

form for packaging for a clinical trial 

study. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and § 952(a) 

and determined that the registration of 

Aptuit to import the basic class of 

controlled substance is consistent with 

the public interest and with United 

States obligations under international 

treaties, conventions, or protocols in 

effect on May 1, 1971, at this time. DEA 

has investigated Aptuit to ensure that 

the company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and § 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic class of controlled substance 

listed. 

Dated: September 11, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–22451 Filed 9–17–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances 

Notice of Registration 

By Notice dated June 15, 2009, and 

published in the Federal Register on 

June 24, 2009, (74 FR 30111), AllTech 

Associates Inc., 2051 Waukegan Road, 

Deerfield, Illinois 60015, made 

application to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of the basic classes of 

controlled substances listed in 

schedules I and II: 

Drug Schedule 

Gamma Hydroxybutyric Acid 

(2010).

I 

Heroin (9200) ............................... I 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Hydrocodone (9193) ..................... II 

Meperidine (9230) ........................ II 

Methadone (9250) ........................ II 

Morphine (9300) ........................... II 

The company plans to import these 

controlled substances for the 

manufacture of reference standards. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and § 952(a) 

and determined that the registration of 

AllTech Associates, Inc. to import the 

basic classes of controlled substances is 

consistent with the public interest and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971, at 

this time. DEA has investigated AllTech 

Associates, Inc. to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and § 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: September 11, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–22452 Filed 9–17–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a) of Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on July 2, 2009, GE 

Healthcare, 3350 North Ridge Avenue, 

Arlington Heights, Illinois 60004–1412, 

made application by renewal to the 

Drug Enforcement Administration 

(DEA) as a bulk manufacturer of Cocaine 

(9041), a basic class of controlled 

substance in schedule II. 

The company plans to manufacture a 

radioactive product used in diagnostic 

imaging in the diagnosis of Parkinson’s 

Disease and for manufacture in bulk for 

investigational new drug (IND) 

submission and clinical trials. 

Any other such applicant, and any 

person who is presently registered with 

DEA to manufacture such a substance, 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, VA 22152; and must be 

filed no later than November 17, 2009. 

Dated: September 14, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–22503 Filed 9–17–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances Notice of Registration 

By Notice dated June 3, 2009, and 

published in the Federal Register on 

June 9, 2009, (74 FR 27350), Norac Inc., 

405 S. Motor Avenue, P.O. Box 577, 

Azusa, California 91702–3232, made 

application by letter to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

Nabilone (7379), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to manufacture 

the bulk controlled substance for use in 

product development and for 

distribution to its customers. 

No comments or objections have been 

received. DEA has considered the 


erowe on DSK5CLS3C1PROD with NOTICES